Landscapes / Targets

PCSK9

10 drugs act on PCSK9, in 42 active trials · Any stage · updated 18 Nov 2026

FollowEvery change as it happens, and a Monday email

Drugs10

DrugHow it worksCompanyStageNext dateDetails
Inclisirannot checked
Small interfering RNA
Approved 27 Nov 2026soonPhase 4 trial completes
Monoclonal antibody
Regeneron · Public REGN
Approved 29 Dec 2026Phase 2 trial completes
Monoclonal antibody
Amgen · Public AMGN
Approved 29 May 2027Phase 4 trial completes
—
Merck & Co. · Public MRK
Approved 12 Oct 2027Phase 2 trial completes
—
Approved 31 Jul 2028Phase 3 trial completes
—
Approved —
—
AstraZeneca · Public AZN
Phase 3 4 Jan 2027Phase 3 trial completes
—
Phase 3 7 Oct 2027Phase 3 trial completes
—
Phase 2 30 Jun 2027Phase 2 trial completes
—
Eli Lilly · Public LLY
Phase 2 Aug 2028Phase 2 trial completes

About this list

Checked
8 of 10 drugs. The other 2 are marked “not checked” in the list. How we check
Matches
The mechanism of checked drugs, and drug names, so a drug not checked yet may be missing.
Sources
ClinicalTrials.gov updated 18 Nov 2026 · openFDA updated 17 Nov 2026

Follow PCSK9

Following is part of Solo: you see every change to PCSK9 the day it happens.

Solo

$49a month, excl. VAT

  • Follow up to 5 landscapes, companies or drugs
  • Every change, the day it happens
  • A Monday email with the week’s changes
Choose Solo

Free

$0no card

  • One landscape of your own, in full
  • The top 10 of everything else
Sign up free

Have an account? Sign in